THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Aigen Investment Management, LP's Holding History (CIK: 0001741224)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023

Shares 23,719 Value ($000) $257 Avg Close $10.57 Range $9.25 - $11.52

Q3 2020

Shares 4,663 Value ($000) $69 Avg Close $18.73 Range $14.62 - $22.82

Q2 2020

Shares 13,429 Value ($000) $282 Avg Close $25.69 Range $20.17 - $31.35

Q1 2020

Shares 9,952 Value ($000) $230 Avg Close $25.03 Range $16.86 - $31.54

Q4 2019

Shares 19 Value ($000) $0 Avg Close $19.43 Range $15.72 - $26.47

Period	Shares	Value ($000)	Average Close	Price Range
Q1 2023	23,719	$257	$10.57	$9.25 - $11.52
Q3 2020	4,663	$69	$18.73	$14.62 - $22.82
Q2 2020	13,429	$282	$25.69	$20.17 - $31.35
Q1 2020	9,952	$230	$25.03	$16.86 - $31.54
Q4 2019	19	$0	$19.43	$15.72 - $26.47